U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819345) titled 'Impact of PREMs in the Shared Decision Process for Renal Replacement Treatment Methods.' on Feb. 05.
Brief Summary: The French "my health 2022" plan is the first bundled payment initiative for stage 4 and 5 chronic kidney disease (CKD) pathway with the aim to improve the quality of care and promote a multi professional collaboration for a more holistic approach of healthcare. Renal Replacement therapies (RRT) have a significant impact on the quality of life and autonomy of patients and their caregivers. The transition to these treatments is a critical point in the pathway, involving a complex choice for patients that cannot be based...